Q2 2025 Definitive Healthcare Corp Earnings Call Transcript
Key Points
- Definitive Healthcare Corp (DH) exceeded the high end of their guidance ranges for both revenue and adjusted EBITDA in Q2 2025.
- The company reported a modest improvement in renewal rates, indicating positive effects from investments in customer success.
- New logo activity remained healthy across core end markets, validating the value proposition of their differentiated data.
- The company increased the midpoint of their revenue guidance and adjusted EBITDA target for the year, reflecting confidence in their strategic direction.
- Definitive Healthcare Corp (DH) is seeing early traction with a global strategic data partnership, contributing to revenue growth.
- Total revenue for Q2 2025 was $60.8 million, representing a 5% decline year-over-year.
- Subscription revenue declined by 6% year-over-year, indicating ongoing pressures in this area.
- The company is experiencing elongated sales cycles, particularly in the life sciences sector.
- There are pressures on renewals due to macroeconomic conditions, including regulatory uncertainty and interest rates.
- The company faces challenges with upsell pressures within the life sciences segment, impacting net dollar retention.
Welcome to Definitive Healthcare's Q2 2025 earnings call. Later, we will conduct a question and answer session. I would now like to turn the call over to your host. You may begin.
Good afternoon. Thank you for joining us today to review Definitive Healthcare's financial results. Joining me on the call today are Kevin Coop, Chief Executive Officer; and Casey Heller, Chief Financial Officer.
During this call, we will make forward-looking statements, including, but not limited to, statements related to our market and future performance and growth opportunities, the benefits of our differentiated data and health care commercial intelligence solutions, our competitive position, customer behaviors and use of our solutions, customer growth, renewals and retention, our financial guidance, our planned investments and operational strategy, generating value for our customers and shareholders.
The anticipated impacts of global macroeconomic conditions on our business results
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
